1.STUDIES ON THE PROTECTIVE IMMUNITY OF Sj 60-90 KD IMMUNOGEN IN SCHISTOSOMA JAPONICUM
Chinese Journal of Schistosomiasis Control 1989;0(03):-
The 60-90 KD antigen of Schistosama japanicum isolated from SEA by SDS-PAGE was used to immunize female C57BL/6 mice viasubcutaneous injection route. Protective immunity against challenge infection with cercariae of S. japonicum was evaluated by the adult worm reduction rate, and the levels on humoral and cellular immunity in immunized mice.A high level of anti-SEA antibody litre in sera collected from immunized mice was detected by ELISA. The value of the adult worm reduction rate showed that there was no significant protective effect on challenge infection and no obvious difference beween immunized mice and non-immunized control groups. In addition, the data of T-cell proliferative response to ConA of spleen cells revealed that 60-90 KD antigen inhibited the response of T-cell to the mutagen. The possibility of induction of different results of immunity was discussed.
2.Cai Wanru`s Experience in Treating Bronchial Asthma
Journal of Zhejiang Chinese Medical University 2014;(10):1163-1164,1165
Objective] To summarize the diagnosis and treatment of Professor Cai Wanru, famous Chinese medicine doctor of the state, the tutor of doctoral student in treating bronchial asthma. [Method] The author studies from the teacher, col ecting medical records, analyzing and learning the dialectical thinking and prescriptions of Professor Cai during treating bronchial asthma. [Results] According to the different stages of bronchial asthma, Professor Cai adopts the combination of differentiation and disease differentiation, uses Chinese medicine to treat bronchial asthma. We should clean lung and phlegm, smoothen breathing during exacerbation of asthma, invigorate the spleen and tonify the lung qi during remission of asthma, at the same time advocate treating winter disease in summer during consolidating period. In addition, clearing lung and regulating Qi should be used throughout al the course of disease. Professor Cai is good at using drug pairs and Chinese medicine flexibly, simply, effectively. [Conclusion] Professor Cai Wanru has been engaged in clinical respiratory department of internal medicine for a long time, having rich experience and unique insights on bronchial asthma, chronic cough, chronic obstructive pulmonary disease and other common respiratory system disease, worth learning.
3.Relationship between coronary remodeling patterns and clinical presentation:an intravascular ultrasound study
Zhexun LIAN ; Shanglang CAI ; Seungjea TANK
Chinese Journal of Ultrasonography 1993;0(03):-
1.1 ), constrictive remodeling(RI 0.05 ). However, more culprit lesions with compensatory remodeling were present in patients with ACS(49% vs 12%, P
4.Factors relating to cross infection in hospital of cancer patients
Yingni LIAN ; Yuecheng CAI ; Jinhui YE ;
China Oncology 1998;0(01):-
Purpose:To investigate the susceptible factors and treatment against cross infection in hospital of cancer patients.Methods:174 cases of cross infection in hospital of cancer patients from 1997 to 1999 were analyzed for infective site, infective agent and infectious bacteria. Results:174 cases of cross infection in hospital of cancer patients were found, which was 10.45% of the in paitents of the same period. The majority (108/174) had infection of tissues and organs within irradiation fields after radiotherapy. Respiratory tract infection rate was 76.43%. 16 cases (40.0%) were found to have secondary infection of digestive canal after chemotherapy in the 40 cases of infection of digestive canal. Bone marrow deression or chronic failure and long term decubitus were also causes of infection. In addition, mycotic infection was 43.42% (33/76) in bacteriological tests with bad prognosis.Conclusions:Cross infection in the hospital occurs that patients enfeebled by radiotherapy, chemotherapy, chronic bone marrow failure and long term decubitus. Attention should be paid to the possibility of mycotic cross infection in hospitals, as the prognosis could be quite serious. As soon as the diagnosis is confirmed, early and full dose treatment by anti mycotic drugs should be given.
5.Contrast analysis of corneal flap thickness using Moria M290 and 110 microkeratome
yan, CHEN ; xin, SUN ; jing-cai, LIAN
Journal of Shanghai Jiaotong University(Medical Science) 2006;0(02):-
Objective To analyze the corneal flap thickness in laser in situ keratomileusis(LASIK) using Moria M2 microkeratome and to identify the related factors. Methods Sixty patients with LASIK were divided into two groups: M2 90 group,using the Moria M2 90 microkeratome,n=30;M2 110 group,using the Moria M2 110 microkeratome,n=30.All were performed on both eyes with the right one treated first.Subtraction pachymetry was used to measure corneal flap thickness which was analyzed statistically with the data including age,preoperative corneal diameter,curvature,corneal thickness and refraction. Results In the 30 patients of M2 90 group,the mean corneal flap thickness of right eye and left eyes were(128.03?12.03)?m(105~156 ?m) and(123.40?12.38) ?m(92~147 ?m),respectively,and the corneal flap thickness were statistically different between the right and left eyes(P
6.Advances in molecular chaperones regulating yeast prion [ PSI+] propagation
Kangwei LIN ; Huiyong LIAN ; Peng CAI
Military Medical Sciences 2015;(9):721-724
The finding and research on yeast prion are of great values for biology and medical sciences.Research advances in molecular chaperones, especially in Hsp104p, Hsp70p and Hsp40p, regulating yeast prion [PSI+] propaga-tion,are reviewed.
7.Evaluation of operative risk and suvival of colorectal cancer patients 80 years of age and older
Peng LIAN ; Weilie GU ; Sanjun CAI ; Shanjing MO
Chinese Journal of Digestion 2010;30(6):391-393
Objective To estimate the operative risk and outcomes of colorectal cancer patients 80 years of age and older. Methods Colorectal cancer resection was performed in 99 patients 80 years of age and older between Dec. 1987 and June 2005. The informations about clinical data, co-morbidity,complications, operative mortality and survival were retrospectively analyzed. The patients were followed-up for 45.12 months (range 1-136) months. Results Of 99 patients, co-morbidity was found in 43 patients (43.4% ) and complication in 10 patients (10.1%). No patient died of operation.Eighty patients completed the follow-up study. The overall 3-year survival rate and disease-free survival rate were 64.3% and 61.1%, respectively. Whereas the overall 5-year survival rate and disease-free survival rate were 52.8% and 52.1%, respectively. In univariate analysis, curative or palliative operation, tumor differentiation, cancer embolism in the vasculature, tumor staging and complications were proved to be significant prognostic factors. Multivariate survival analysis,however, showed that only the curative or palliative operation was independent factor for survival.Conclusions The high risk of co-morbidity for patients 80 years of age and older is not the obstacle to cancer resection.These patients will have satisfactory outcomes via optimal treatment and operation.
8.Nursing of percutaneous and transhepatic portal venous autologous bone marrow stem cell transplantation
Yinke CAI ; Wanbin LI ; Rongli LIAN ; Liang PENG ; Wenxiong XU
Chinese Journal of Practical Nursing 2011;27(13):52-53
Objective To summarize the nursing experience of treatment of percutaneous and transhepatic portal venous autologous bone marrow stem cell transplantation for chronic hepatic failure.Methods 19 patients who were definitely diagnosed as chronic liver failure received pertinent nursing in different perioperative period of transhepatic portal venous autologous bone marrow stem cell transplantation.Results All of the 19 patients went through perioperative period safely without any adverse reactions or complications.Conclusions In the process of treatment of autologous bone marrow stem cell transplantation for chronic hepatic failure,sufficient preoperative preparation,good communication and close cooperation among doctors,nurses and patients during operation,careful nursing and rehabilitation instruction after operation,are important assurances for autologous bone marrow stem cell transplantation to run smoothly.
9.Analysis of the effects of miRNAs on the expression of cytokines by THP-1 cells using Luminex xMAP technology
Lian GUI ; Qianqian ZHANG ; Yan CAI ; Qi GUO ; Junqi HUANG
Chinese Journal of Microbiology and Immunology 2015;(11):799-805
Objective To investigate the effects of a miRNA family member, let-7e, and a combi-nation of miR-106b and miR-20a on the expression of cytokines by THP-1 cells with Luminex xMAP technol-ogy.Methods The efficiency of transfection was evaluated by immunofluorescence assay after transfecting THP-1 cells with micrONTM mimic negative control (Cy3) for 24 h, 36 h and 48 h.The three miRNA mim-ics (let-7e, miR-106b and miR-20a) were respectively used to transfect the THP-1 cells for 24 h, 36 h and 48 h and the expression of each miRNA was analyzed by qRT-PCR analysis for screening out the optimal transfection time.The transfected THP-1 cells were stimulated with1 mg/L of LPS for 1 h.The Luminex xMAP technology was used to detect the expression of IL-8, interferon-inducible protein-10 (IP-10), mono-cyte chemotactic protein 1 (MCP-1), IL-1α, IL-6, IL-10, TNF-α, IFN-αand IFN-βin the supernatants of cell culture.A statistical analysis was performed to analyze the data obtained by using SPSS16.0 software. Results More than 90% of the transfected THP-1 cells were labeled with red fluorescence.The optimal transfection times for let-7e mimic and miR-106b/miR-20a mimics were 48 h and 24 h, respectively.Com-pared with the corresponding negative control (NC), the expression of IL-8, IP-10 and MCP-1 by THP-1 cells were enhanced after the transfection with let-7e mimic, but were inhibited after the co-transfection with miR-106b and miR-20a mimics.Conclusion The expression of IL-8, IP-10 and MCP-1 were enhanced in let-7e transfected THP-1 cells, but were inhibited in miR-106b and miR-20a co-transfected THP-1 cells.
10.Effect of Ulinastatin on T-cytoimmunity in patients with infetility undergoing laparoscopic surgery
Lian DENG ; Zurong HU ; Jing YI ; Danchen SU ; Chengyi CAI
The Journal of Practical Medicine 2015;(13):2081-2083
Objective To research the effect of ulinastatin on T-cytoimmunity in patients with infertility undergoing laparoscopic surgery. Methods Forty patients scheduled for receiving laparoscopic surgery were equally randomized into two groups, ulinastatin group (Group U) and control group (Group C). Ulinastatin was given to patients in the Group U at a dose of 20 × 104 U before anesthetic. No ulinastatin was given to patients in the Group C. Patients′venous blood samples for T-lymphocyte subset (CD3+,CD3+CD4+,CD3+CD8+) and CD3+CD4+/ CD3+CD8+ ratio calculation were collected before the surgery (T0) and at 0 h (T1),1st day (T2),3rd day (T3) after the surgery. Results CD3+ had less difference at T1~3 compared with T0 in the Group C but raised obviously at T2~3 in the Group U. CD3+CD4+ were only raised at T3 compared with T0 but raised obviously at T2~3 in the Group U. CD3+CD8+ were raised obviously at T2~3 compared with T0 in the Group C but had less difference in the Group U. CD3+CD4+/CD3+CD8+ had less difference at T1~3 compared with T0 in the Group C but raised obviously at T3 in the Group U. Conclusion The application of ulinastatin in laparoscopic surgery could significantly produce protective effect on T-cytoimmunity.